WO2012060789A3 - Production method for cefdinir formulations - Google Patents

Production method for cefdinir formulations Download PDF

Info

Publication number
WO2012060789A3
WO2012060789A3 PCT/TR2011/000254 TR2011000254W WO2012060789A3 WO 2012060789 A3 WO2012060789 A3 WO 2012060789A3 TR 2011000254 W TR2011000254 W TR 2011000254W WO 2012060789 A3 WO2012060789 A3 WO 2012060789A3
Authority
WO
WIPO (PCT)
Prior art keywords
production method
cefdinir
formulations
cefdinir formulations
processes
Prior art date
Application number
PCT/TR2011/000254
Other languages
French (fr)
Other versions
WO2012060789A2 (en
Inventor
Mahmut Bilgic
Original Assignee
Mahmut Bilgic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TR2010/09167A external-priority patent/TR201009167A2/en
Application filed by Mahmut Bilgic filed Critical Mahmut Bilgic
Publication of WO2012060789A2 publication Critical patent/WO2012060789A2/en
Publication of WO2012060789A3 publication Critical patent/WO2012060789A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to processes to be used for preparation of formulations comprising cefdinir as the active agent and pharmaceutical compositions to be obtained by this process.
PCT/TR2011/000254 2010-11-05 2011-11-03 Production method for cefdinir formulations WO2012060789A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
TR2010/09167 2010-11-05
TR2010/09167A TR201009167A2 (en) 2010-11-05 2010-11-05 Pharmaceutical granules containing cephalosporin.
TR2010/10860 2010-12-24
TR2010/10860A TR201010860A2 (en) 2010-11-05 2010-12-24 Production method for cefdinir formulations.

Publications (2)

Publication Number Publication Date
WO2012060789A2 WO2012060789A2 (en) 2012-05-10
WO2012060789A3 true WO2012060789A3 (en) 2012-06-28

Family

ID=45607339

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/TR2011/000254 WO2012060789A2 (en) 2010-11-05 2011-11-03 Production method for cefdinir formulations
PCT/TR2011/000258 WO2012060793A2 (en) 2010-11-05 2011-11-03 Process for the preparation of cefdinir formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/TR2011/000258 WO2012060793A2 (en) 2010-11-05 2011-11-03 Process for the preparation of cefdinir formulations

Country Status (2)

Country Link
TR (1) TR201010860A2 (en)
WO (2) WO2012060789A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281200A1 (en) * 1987-03-02 1988-09-07 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
CA2393614A1 (en) * 2002-07-19 2002-10-28 Abbott Laboratories Antibacterial clarithromycin compositions and processes for making the same
WO2004006917A1 (en) * 2002-07-16 2004-01-22 Ranbaxy Laboratories Limited Dispersible tablets for oral administration
WO2005115347A1 (en) * 2004-05-31 2005-12-08 Sam-A Pharmaceuticals Co., Ltd. Dispersible tablet comprising beta lactam antibiotics and process for preparing the same
WO2007058397A1 (en) * 2005-11-17 2007-05-24 Gl Pharmtech Corp. A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836918B (en) 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281200A1 (en) * 1987-03-02 1988-09-07 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
WO2004006917A1 (en) * 2002-07-16 2004-01-22 Ranbaxy Laboratories Limited Dispersible tablets for oral administration
CA2393614A1 (en) * 2002-07-19 2002-10-28 Abbott Laboratories Antibacterial clarithromycin compositions and processes for making the same
WO2005115347A1 (en) * 2004-05-31 2005-12-08 Sam-A Pharmaceuticals Co., Ltd. Dispersible tablet comprising beta lactam antibiotics and process for preparing the same
WO2007058397A1 (en) * 2005-11-17 2007-05-24 Gl Pharmtech Corp. A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same

Also Published As

Publication number Publication date
WO2012060789A2 (en) 2012-05-10
WO2012060793A3 (en) 2012-06-28
TR201010860A2 (en) 2012-05-21
WO2012060793A2 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
WO2014014835A8 (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
WO2011093832A3 (en) Stable efervescent formulations comprising cefaclor
WO2010092090A3 (en) Novel salts of sitagliptin
WO2012021715A3 (en) Stable formulations of linaclotide
MY164274A (en) Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2010139979A3 (en) Processes for preparing crystalline forms of dasatinib
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
WO2012040804A3 (en) Synergistic combinations of triazoles, strobilurins and benzimidazoles, uses, formulations, production processes and applications using the same
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
WO2014068586A3 (en) Solid oral compositions of tolvaptan
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
MX339361B (en) Alternan derivatives.
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2011045774A3 (en) Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
WO2011139249A3 (en) Pharmaceutical composition comprising cefdinir
WO2012122451A3 (en) Polymorphs of maxacalcitol and process for the preparation of maxacalcitol
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent
WO2011095985A3 (en) Rasagiline salts and processes for the preparation thereof
MX2013012773A (en) Drug substances, pharmeceutical compositions and methods for preparing the same.
WO2012019428A8 (en) Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
WO2011031099A3 (en) Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same
WO2012007758A3 (en) Pharmaceutical formulations
WO2012060791A3 (en) Production method for pharmaceutical compositions comprising cefdinir
EP2611446A4 (en) Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11817552

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11817552

Country of ref document: EP

Kind code of ref document: A2